Looking for:
prednisolone |
Amongst the different subpopulations the occurrence of scleroderma renal crisis varies. The highest risk has been reported in patients with diffuse systemic sclerosis. The lowest risk has been reported in patients with limited systemic sclerosis (2%) and juvenile onset systemic sclerosis (1%).
Black Listed Medicines - These drugs are considered inappropriate for prescribing in Coventry & Warwickshire as they are either not cost-effective or of proven benefit or both. Specialist Initiation - These drugs must be initiated, i.e. the first dose prescribed, by the specialist and then may be continued when appropriate by the patient’s GP following communication from the specialist. Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety. No drugs listed in this BNF section - see BNF for general information on infection control in relation to the use of eye preparations.
These would include depressive or manic-depressive illness and previous steroid psychosis. Caution is required in patients with systemic sclerosis because of an increased incidence of scleroderma renal crisis with hypertension and decreased urinary output observed with a daily dose of 15 mg or more prednisolone. Blood pressure and renal function (s-creatinine) should therefore be routinely checked. When renal crisis is suspected, blood pressure should be carefully controlled.
You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site. Use in patients with severe Chronic Allergic Eye Disease who present to A&E with a flare up. New medicines, devices, appliances.New indication of existing medicine.New NICE TA which has not been reviewed.Not been requested for review by either TAS/LPT MMC. Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR. Acute courses to induce remission only - not licensed or NICE recommended for maintenance of remission. Irritability, depressed and labile mood, suicidal thoughts, psychotic reactions, mania, delusions, hallucinations, and aggravation of schizophrenia.
Hypoadrenalism may, in theory, occur in the neonate following prenatal exposure to corticosteroids but usually resolves spontaneously following birth and is rarely clinically important. Cataracts have been observed in infants born to mothers treated with long-term prednisolone during pregnancy. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.
Carbamazepine, phenobarbital, phenytoin, and primidone accelerate metabolism of corticosteroids and may reduce their effect. The absorption of prednisolone may be reduced by large doses of some antacids such as magnesium trisilicate or aluminium hydroxide. Systemic glucocorticoid treatment can cause severe exacerbation of bullous exudative retinal detachment and lasting visual loss in some patients with idiopathic central serous chorioretinopathy (see section 4.8). Corticosteroids should be used cautiously in patients with ocular herpes simplex because of possible perforation. • Corticosteroid requirements may be reduced in menopausal and post-menopausal women.
These drugs should only be prescribed in the scenarios described in the formulary after preferred drug have been ruled out. Prescribers need to be aware of the Cortiment® contraindication for patients with a soya or peanut allergy, particularly if switching from the other brands of budesonide for which this contraindication does not apply. New drugs classified as red or amber but as greater experience regarding their safety and efficacy is established may move to Green after re-consideration by the HHMC. Drugs not included in the Traffic Light list but included on joint formulary. Prednisolone soluble can be up to 200 times more costly than plain tablets depending on the setting.
The desired effects of hypoglycaemic agents , antihypertensives and diuretics are antagonised by corticosteroids; and the hypokalaemic effect of acetazolamide, loop diuretics, thiazide diuretics, carbenoxolone and theophylline are enhanced. Oestrogens may potentiate the effects of glucocorticoids and dosage adjustments may be required if oestrogens are added to or withdrawn from a stable dosage regimen. Drugs that inhibit hepatic enzyme cytochrome P-450 isoenzyme 3A4 (e.g. ketoconazole, troleandomycin) may decrease glucocorticoid clearance.
The potential advantage of soluble or enteric coated preparations to reduce the risk of gastric ulcers is speculative. To minimise long-term adverse effects use the lowest effective dose for the shortest possible time. Please note that the prednisolone 20mg/application foam enema is significantly more expensive than the budesonide 2 mg per 1 actuation foam enema . Significant differences in the pharmacokinetics of prednisolone amongst menopausal women have been described. The postmenopausal women had reduced unbound clearance (30%), reduced total clearance and increased half-life of prednisolone.
Comments
Post a Comment